Nipro (FRA:5FA) Inventories, Raw Materials & Components: €324 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5FA Nipro Corp FRA:5FA
77 GF Score
Price €8.60
GF Value €7.83
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Nipro Inventories, Raw Materials & Components?

Nipro FRA:5FA -1.71% 77 Inventories, Raw Materials & Components is €324 Mil as of Mar. 2026. GuruFocus rates FRA:5FA with a GF Score™ of 77/100 and a GF Value™ of €7.83 (Fairly Valued). The stock has 6 warning signs investors should review.

Nipro's inventories, raw materials & components for the quarter that ended in Mar. 2026 was €324 Mil.

Nipro's quarterly raw materials declined from Sep. 2025 (€333 Mil) to Dec. 2025 (€321 Mil) but then increased from Dec. 2025 (€321 Mil) to Mar. 2026 (€324 Mil).

Nipro's annual raw materials increased from Mar. 2024 (€343 Mil) to Mar. 2025 (€367 Mil) but then declined from Mar. 2025 (€367 Mil) to Mar. 2026 (€324 Mil).

Nipro Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Nipro's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nipro Inventories, Raw Materials & Components Chart

Nipro Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 327.75 367.50 343.36 367.06 323.63

Nipro Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 367.06 349.92 333.37 321.37 323.63
FRA:5FA
77GF Score
Nipro Corp FRA:5FA
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nipro Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €324 Mil mean?
Nipro (FRA:5FA) has a Inventories, Raw Materials & Components of €324 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Nipro and its competitors.
Is Nipro's Inventories, Raw Materials & Components too high?
Nipro's current Inventories, Raw Materials & Components is €324 Mil. Overall, Nipro has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nipro's Inventories, Raw Materials & Components compare to ISRG and BDX?
Nipro's Inventories, Raw Materials & Components of €324 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Nipro and its competitors. Nipro's current Inventories, Raw Materials & Components is €324 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nipro stock overvalued right now?
Based on GuruFocus' analysis, Nipro (FRA:5FA) is currently considered Fairly Valued. The stock's GF Value™ is €7.83, compared to a current price of €8.60 — trading 9.8% above its estimated fair value. The current Inventories, Raw Materials & Components is €324 Mil. Nipro's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Nipro (FRA:5FA), the current Inventories, Raw Materials & Components is €324 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nipro (FRA:5FA) Overvalued in 2026?

Based on GuruFocus' analysis, Nipro stock appears to be overvalued. The current stock price of €8.60 is trading 9.8% above its estimated GF Value™ of €7.83. GuruFocus considers Nipro to be Fairly Valued.

Key valuation signals for FRA:5FA:

  • Inventories, Raw Materials & Components: €324 Mil
  • GF Value™: €7.83 vs. price of €8.60 (9.8% above fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the FRA:5FA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nipro Business Description

Other Exchanges 8086:Japan
Address 3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
77GF Score

Get the complete analysis for FRA:5FA

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.60
Price
€7.83
GF Value